APN is proud to be a part of recovery and mental health research to create more efficient and effective treatments for people in all stages of health and healing.
BETTER TREATMENTS. BETTER OUTCOMES.PSYCHEDELIC RESEARCH
Since the inception of APN, we’ve had a vision for addiction and mental health care that champions outcomes through whole-person care, integrated modalities, and evidence-based innovation. Now, APN is proud to be a part of the research that discovers new frontiers and new front doors in healing.
INTRODUCING OUR CENTER OF EXCELLENCE with Journey Colab
APN is proud to announce its partnership with Journey Colab to create the first-of-its-kind Center of Excellence for Psychedelic Research and Care – dedicated to research and implementation of psychedelic interventions and best practices in the clinical treatment of substance use disorders. APN is honored to bring Journey Colab’s model of care and immense biopharmaceutical experience and psychedelic medicine expertise into its Plus by APN location in Boulder, CO. The partnership’s first endeavor will be an FDA-authorized clinical trial of a psychedelic therapeutic in phase 2+ of development for the treatment of Alcohol Use Disorder in the context of a real-world treatment setting.
/*----POST CTA JS Start from here --*/
/*-- End Here --*/
Understanding Psychedelic Research in Mental Health
Psychedelic research represents a groundbreaking shift in how mental health and addiction disorders are approached. With a focus on substances like psilocybin and MDMA, studies have shown promising results in treating conditions such as PTSD, depression, and anxiety. This innovative research aims to redefine therapeutic practices by incorporating these substances into treatment protocols.
Recent clinical trials have demonstrated the efficacy of psychedelic-assisted therapy, revealing significant improvements in patient outcomes. For instance, studies have indicated that participants receiving psilocybin treatment reported lasting reductions in depressive symptoms compared to traditional therapies. As APN collaborates with Journey Colab, they aim to further explore these treatments, ensuring they are safe, effective, and accessible to those in need.
The Role of the Center of Excellence for Psychedelic Research
The Center of Excellence for Psychedelic Research, established through the partnership between APN and Journey Colab, serves as a hub for innovation in therapeutic practices. Its mission is to advance research, develop new treatment protocols, and provide comprehensive training for clinicians in the field of psychedelic medicine.
By leveraging Journey Colab's extensive experience in biopharmaceuticals, the center aims to foster a collaborative environment where researchers, practitioners, and patients can benefit from cutting-edge advancements. This initiative not only enhances the quality of care offered at APN but also contributes to the broader understanding of how psychedelics can be integrated into mental health treatment frameworks.
Benefits of Psychedelic-Assisted Therapy
Psychedelic-assisted therapy offers numerous benefits for individuals struggling with mental health challenges. Unlike conventional treatments, this approach can lead to profound psychological shifts, often resulting in lasting changes in perspective and emotional well-being. Patients frequently report increased feelings of connectedness and decreased anxiety after sessions.
Moreover, the therapeutic effects of psychedelics can facilitate deeper introspection, enabling patients to confront underlying issues that contribute to their conditions. APN's commitment to evidence-based practices ensures that these therapies are implemented with care and consideration, maximizing their potential to transform lives.
How to Get Involved in Psychedelic Research
Individuals interested in participating in psychedelic research can explore various opportunities at APN. The center frequently seeks volunteers for clinical trials and studies aimed at understanding the efficacy of psychedelic treatments. Participation not only contributes to valuable research but also provides individuals access to innovative therapies that may enhance their mental health.
To get involved, prospective participants can reach out to APN for information on current studies and eligibility criteria. Engaging in this research offers a unique chance to be at the forefront of mental health treatment advancements, helping shape the future of care for those struggling with addiction and mental health disorders.
Understanding Psychedelic Research in Mental Health
Psychedelic research represents a groundbreaking shift in how mental health and addiction disorders are approached. With a focus on substances like psilocybin and MDMA, studies have shown promising results in treating conditions such as PTSD, depression, and anxiety. This innovative research aims to redefine therapeutic practices by incorporating these substances into treatment protocols.
Recent clinical trials have demonstrated the efficacy of psychedelic-assisted therapy, revealing significant improvements in patient outcomes. For instance, studies have indicated that participants receiving psilocybin treatment reported lasting reductions in depressive symptoms compared to traditional therapies. As APN collaborates with Journey Colab, they aim to further explore these treatments, ensuring they are safe, effective, and accessible to those in need.
The Role of the Center of Excellence for Psychedelic Research
The Center of Excellence for Psychedelic Research, established through the partnership between APN and Journey Colab, serves as a hub for innovation in therapeutic practices. Its mission is to advance research, develop new treatment protocols, and provide comprehensive training for clinicians in the field of psychedelic medicine.
By leveraging Journey Colab's extensive experience in biopharmaceuticals, the center aims to foster a collaborative environment where researchers, practitioners, and patients can benefit from cutting-edge advancements. This initiative not only enhances the quality of care offered at APN but also contributes to the broader understanding of how psychedelics can be integrated into mental health treatment frameworks.
Benefits of Psychedelic-Assisted Therapy
Psychedelic-assisted therapy offers numerous benefits for individuals struggling with mental health challenges. Unlike conventional treatments, this approach can lead to profound psychological shifts, often resulting in lasting changes in perspective and emotional well-being. Patients frequently report increased feelings of connectedness and decreased anxiety after sessions.
Moreover, the therapeutic effects of psychedelics can facilitate deeper introspection, enabling patients to confront underlying issues that contribute to their conditions. APN's commitment to evidence-based practices ensures that these therapies are implemented with care and consideration, maximizing their potential to transform lives.
How to Get Involved in Psychedelic Research
Individuals interested in participating in psychedelic research can explore various opportunities at APN. The center frequently seeks volunteers for clinical trials and studies aimed at understanding the efficacy of psychedelic treatments. Participation not only contributes to valuable research but also provides individuals access to innovative therapies that may enhance their mental health.
To get involved, prospective participants can reach out to APN for information on current studies and eligibility criteria. Engaging in this research offers a unique chance to be at the forefront of mental health treatment advancements, helping shape the future of care for those struggling with addiction and mental health disorders.
